A*3301 is a peptide associated with the HLA-A*3301 allele, containing sequence elements that determine anchoring and surface presentation. Researchers use it to investigate MHC-binding stability, epitope conformation, and antigenic determinants. The motif supports structural modeling of peptide-MHC interfaces. Its composition allows controlled biophysical profiling.
CAT No: ta-532
A*3301 is a synthetic peptide corresponding to a specific sequence derived from the human leukocyte antigen (HLA) class I molecule, HLA-A*3301. As a defined peptide reagent, it plays a significant role in immunology and molecular biology research, particularly in studies involving antigen presentation, T cell recognition, and immune system modulation. Its well-characterized sequence allows for precise experimental manipulation, making it a valuable tool for dissecting the molecular mechanisms underlying peptide-MHC interactions and adaptive immune responses. The use of A*3301 supports a range of applications where specificity and reproducibility are crucial for advancing both basic and applied immunological investigations.
Epitope Mapping: Researchers utilize this peptide in epitope mapping studies to identify T cell receptor (TCR) recognition sites within HLA-restricted antigens. By incorporating A*3301 into in vitro assays, scientists can systematically analyze T cell activation, cytokine release, and cytotoxicity in response to defined HLA-presented sequences. This approach helps elucidate the fine specificity of TCR-peptide-MHC interactions, advancing our understanding of immune recognition and facilitating the development of targeted immunotherapies.
T Cell Functional Assays: The defined sequence of A*3301 enables its use in functional assays designed to characterize CD8+ T cell responses. By pulsing antigen-presenting cells with this peptide, investigators can assess T cell proliferation, cytotoxic activity, and cytokine production in a controlled experimental setting. Such assays are essential for evaluating T cell functionality and for screening peptide candidates in vaccine research or immunomodulatory studies.
Peptide-MHC Binding Studies: A*3301 serves as a model ligand in peptide-MHC binding affinity experiments. Its sequence is frequently employed to investigate the structural and thermodynamic parameters governing peptide loading onto HLA-A*3301 molecules. These studies provide insights into the stability of peptide-MHC complexes, contributing to the rational design of peptide-based vaccines and immunotherapeutic agents by revealing the determinants of high-affinity binding.
Immunopeptidomics and Mass Spectrometry: In immunopeptidomics workflows, synthetic peptides such as A*3301 are used as reference standards or spike-in controls for mass spectrometry-based identification and quantification of naturally processed HLA ligands. This application supports the accurate characterization of the immunopeptidome, enabling the identification of candidate neoantigens and the validation of peptide presentation in various biological contexts.
Peptide Library Screening: The peptide's defined structure makes it suitable for inclusion in combinatorial peptide libraries used to screen for novel TCRs, antibodies, or peptide-binding proteins. Such screening platforms rely on the availability of well-characterized peptides like A*3301 to benchmark binding specificity and affinity, thereby accelerating the discovery and optimization of immune modulators and diagnostic reagents. Through these diverse applications, A*3301 provides a robust foundation for advancing immunological research and translational studies focused on antigen presentation and immune recognition.
1. Myotropic activity of allatostatins in tenebrionid beetles
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More